features of ALS and frontotemporal lobar degeneration have been documented (Wegorzewska et al. 2009 ). Complementarily, primary, embryonic or induced pluripotent stem cellbased motoneuron cultures from SOD1 mutant mice or ALS patients are being regarded as a solid approach to gain insights into physio-pathological mechanisms of ALS (Raoul et al. 2006; Nagai et al. 2007; Dimos et al. 2008) .
A dominantly inherited mutation in the gene encoding for the vesicle-associated membrane protein-associated protein B (VAPB) has been associated with typical ALS, atypical ALS and late-onset spinal muscular atrophy (Nishimura et al. 2004) . VAPB is a ubiquitously expressed membraneanchored protein that localizes mainly to the endoplasmic reticulum (ER) and ER-Golgi intermediate vesicles (Soussan et al. 1999; Lev et al. 2008) . VAPB has been proposed to play a role in coat protein complex I-mediated retrograde transport of proteins (Soussan et al. 1999) , lipid transfer toward the Golgi , and also to regulate ER structure through interaction with the microtubule network (Amarilio et al. 2005; Prosser et al. 2008) or to modulate response to ER stress (Kanekura et al. 2006; Gkogkas et al. 2008; Suzuki et al. 2009 ). Studies in neuronal and nonneuronal cell lines showed that the proline 56 to serine (P56S) VAPB mutant forms dense cytosolic aggregates continuous with ER structures. These VAPB P56S inclusions may exert dominant negative effects by recruiting and insolubilizing the wild-type form of VAPB (Kanekura et al. 2006; Teuling et al. 2007; Suzuki et al. 2009 ). However, the impact of mutant VAPB on the functional integrity of motoneurons remains elusive.
Here, we report that adeno-associated viral (AAV) vectormediated expression of both human wild-type and mutant VAPB selectively triggers death of embryonic motoneurons. We provide evidence that ER stress and an impaired calcium (Ca 2+ ) homeostasis participate in the death program initiated by wild-type or mutant VAPB over-expression. We demonstrate that the hVAPB-associated degenerative process occurs in a caspase-dependent manner in cultured motoneurons. We describe an in vitro model of VAPB-associated selective degeneration of motoneurons that provides evidence that Ca 2+ signals associated to ER-derived pathways might contribute to the pathologic loss of motoneurons.
Materials and methods

Expression constructs
Coding sequences of hVAPB (Genbank NM004738) and human vesicle-associated membrane protein-associated protein A (hVAPA) (genebank AK315577) were cloned by PCR from 293T cell cDNA (TA cloning kit, Invitrogen, Carlsbad, CA, USA) using the following primers: 5¢-AAAGGTGCTCCGCCGCTAAG-3¢ (hVAPB sense), 5¢-TTCTTTTCCCCCTCAATCAG-3¢ (hVAPB antisense), 5¢-CCGATGGCGTCCGCCTCAGGGGCC-3¢ (hVAPA sense) and 5¢-CTACAAGATGAATTTCCCTAG-3¢ (hVAPA antisense). To introduce P56S point mutation, site-directed mutagenesis was performed by PCR (QuickChange Site Directed Mutagenesis Kit, Stratagene, La Jolla, CA, USA) using pCR2.1-hVAPB WT as template and the following primer sequence: 5¢-TGTGTGAGGTC-CAACAGCGGAATCA-3¢ (sense). pUbc-enhanced green fluorescent protein (EGFP), pUbc-hVAPB WT , pUbc-hVAPB P56S and pUbc-hVAPA were generated from the pCCL-cPPT-phosphoglycerokinase (PGK1)-WPRE expression vector (Raoul et al. 2005) , in which PGK1 has been replaced by the human ubiquitin c promoter (Araki et al. 2004) . To construct AAV vectors carrying EGFP, hVAPB WT , hVAPB P56S , hVAPA cDNA, we first replaced the cytomegalovirus promoter of pAAV-MCS (Stratagene) by the mouse PGK1 promoter (Raoul et al. 2005) , and then cloned the corresponding cDNA downstream of PGK1 promoter and b-globin intron. All cDNA inserts were sequenced to ensure the integrity of the nucleotidic sequences.
AAV6 production and titration by quantitative real-time PCR
Recombinant AAV serotype 6 vectors were produced as previously described (Towne et al. 2008) , by transient co-transfection of 293AAV cell line with AAV-EGFP, AAV-hVAPB WT , AAVhVAPB P56S or AAV-hVAPA and the helper plasmid pDF6 (Grimm et al. 2003) . Forty-eight hours later, AAV particles were purified from cell lysates on a heparin affinity column using HPLC. The titration of infectious AAV particles was performed in 293T cells by quantitative real-time PCR according to the nuclease S1 methods (Rohr et al. 2005) , as previously described (Towne et al. 2008) . The primers targeting b-globin intron were 5¢-CGTGCCAA-GAGTGACGTAAG-3¢ (sense) and 5¢-TGGTGCAAAGAGGCAT-GATA-3¢ (antisense). Albumin that served as internal control was amplified using the following primers: 5¢-TGAAACATACGTTCC-CAAAGAGTTT-3¢ (sense) and 5¢-CTCTCCTTCTCAGAAAGTGT-GCATAT-3¢ (antisense). The titers of AAV vectors used in the present study, depending on the viral preparation, vary between 2.1 and 2.9 · 10 10 transducing units (TU)/mL for AAV-EGFP; 1.4 and 6.3 · 10 9 TU/mL for AAV-hVAPB WT ; 1.8 and 2.5 · 10 10 TU/mL for AAV-hVAPB P56S ; 2 · 10 9 TU/mL for AAV-hVAPA.
Cell cultures
Motoneurons from E12.5 spinal cord of CD1 (Charles River Laboratories Inc., Wilmington, MA, USA) or Hb9::GFP (T.M. Jessell's laboratory, Columbia University, NY, USA) mice were isolated as described (Arce et al. 1999) and modified (Raoul et al. 2002) using iodixanol density gradient centrifugation. Motoneurons were plated on poly-ornithine/laminin-treated wells in the presence of a cocktail of neurotrophic factors (0.1 ng/mL glial-derived neurotrophic factor, 1 ng/mL brain-derived neurotrophic factor, and 10 ng/mL ciliary neurotrophic factor) in supplemented Neurobasal medium. Cortical and striatal neurons were isolated from E17.5 embryos as described (Raoul et al. 2002; Zala et al. 2005) . Cortical and striatal neurons were plated on poly-ornithine/laminin-treated wells and cultured in Neurobasal medium complemented with 1 mM sodium pyruvate, 2% B27 supplement (Invitrogen). Housing and care of mice were performed in compliance with the European Community and National directives for the care and use of laboratory animals. Cos-7 and NSC34 cells were maintained in Dulbecco Modified Eagle Medium (Invitrogen) supplemented with 10% fetal bovine serum.
For infection of primary neurons, 1 day after plating, half of the culture media was removed and replaced with fresh supplemented media containing AAV particles. Cells were then incubated for 5 h at 37°C, washed and fed again with corresponding supplemented medium.
For survival assays we used the following reagents: tunicamycin, caffeine, dantrolene, 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo (F) quinoxaline (NBQX) and MDL-28170 were from Sigma (St Louis, MO, USA). Thapsigargin and z-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-fmk were from Calbiochem (San Diego, CA, USA). Salubrinal and 1,2-bis(2-Aminophenoxy)ethane-N,N,N¢,N¢-tetraacetic acid tetrakis(acetoxymethyl) ester (BAPTA/AM) were from Alexis Corporation (San Diego, CA, USA). z-Ala-Thr-Ala-Asp(OME)-fmk (z-ATAD-fmk) was purchased from MBL international corporation (Woburn, MA, USA).
VAPB antibodies and Western blotting
Rabbit polyclonal antibodies for human VAPB (DIM-705) were raised using hVAPB peptide TVQSNSPISALAPTG conjugated to keyhole-limpet hemocyanin. Antisera were purified on peptidesepharose affinity column (P.A.R.I.S, Compiègne, France).
Proteins were extracted using lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM EDTA, 2 mM EGTA and 1% sodium dodecyl sulfate) supplemented with a protease inhibitor cocktail (Roche Molecular Biochemicals, Indianapolis, IN, USA). Protein concentration was determined using BCA kit (Pierce, Rockford, IL, USA). Protein samples were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis and blotted to nitrocellulose membranes (Schleicher and Schuell, Whatman International Ltd, Springfield Mill, UK). All membrane blocking steps and antibody dilutions were performed with 6% non-fat dry milk in phosphatebuffered saline (PBS) containing 0.1% Tween-20, and washing steps performed with PBS containing 0.1% Tween-20. The following antibodies were used: anti-hVAPB (DIM-705, 1 : 4000), anti-VAPA (sc-48698, Santa Cruz Biotechnology, Santa Cruz, CA, USA; 1 : 1000), anti-EGFP (TP401, Torrey Pines Biolabs (East Orange, NJ, USA); 1 : 5000), anti-phospho inositol-requiring enzyme 1 (IRE1) (ab48187, Abcam (Cambridge, MA, USA); 1 : 200), anti-actin (AC-40; Sigma-Aldrich; 1 : 20 000). Proteins were then detected using horseradish peroxidase-conjugated secondary antibodies and visualized with the chemiluminescent horseradish peroxidase substrate (Millipore Corporation, Bedford, MA, USA).
Immunocytochemistry
Cells were cultured onto poly-ornithine/laminin-treated glass coverslips at a density of 5000 cells per cm 2 and at indicated times fixed in 3.7% formaldehyde for 20 min at 20°C. Cells were washed thrice with PBS and then blocked for 1 h in PBS, 0.1% Triton X-100, 4% bovine serum albumin and 5% heat-inactivated donkey serum. 
Statistical analyses
Statistical analyses were performed by unpaired two-tailed t test or by a one-way analysis of variance (ANOVA) followed by a StudentNewman-Keuls's post hoc test using the GraphPad Instat software (GraphPad Software, La Jolla, CA, USA). Significance was accepted at the level of p < 0.05.
Results
AAV-mediated expression of hVAPB P56S leads to the formation of cytoplasmic aggregates in embryonic motoneurons To investigate the functional consequences of the expression of the ALS-linked human VAPB P56S mutant (hVAPB
P56S
) in motoneurons, we developed an in vitro model based on AAVmediated gene transfer. Using a recombinant AAV serotype 6 driving expression of the enhanced green fluorescent protein (AAV-EGFP) (Fig. 1a) , we showed that AAV provide a simple and efficient means of stable gene expression in the motoneuron culture system. Indeed, at the multiplicity of infection (m.o.i) of 10 TU per cell (3 · 10 4 TU/mL), AAV serotype 6 can transduce up to 90% of motoneurons, with an early and sustained transgene expression (detectable from 6 h to 15 days post-infection) and limited toxicity (Appendix S1).
Adeno-associated viral constructs were then engineered to achieve expression of human VAPB wild-type (AAVhVAPB WT ), VAPB mutant (AAV-hVAPB
) or hVAPA (AAV-hVAPA), a member of the VAP family, which has not been linked to motoneuron disease. To facilitate the detection of hVAPBs, we generated polyclonal antibodies that specifically recognize human VAPB, both in western blot and immunocytochemistry . We confirmed by western blot the ability of AAV-hVAPB WT , AAV-hVAPB
and hVAPA viral vectors to drive expression of their corresponding transgene (Fig. 1b) . In accordance with previous reports (Kanekura et al. 2006; Suzuki et al. 2009 ), we observed that steady-state levels of hVAPB P56S were lower than that of hVAPB WT , even though cells were infected with the same m.o.i. We next evaluated the cellular distribution of hVAPB WT , hVAPB P56S and hVAPA in motoneurons. Although, we showed functional AAV-mediated VAPA expression by western blot (Fig. 1b) , we were not able, with the available antibodies, to specifically detect the human form of VAPA by immunofluorescence in motoneurons. We showed that hVAPB WT co-localizes with KDEL, an ER marker and with b-COP a component of coat protein complex I vesicles in motoneurons ( Fig. 1c-f ). Whereas, AAV-mediated expression of hVAPB P56S leads to the formation of cytoplasmic aggregates that frequently co-localized with KDEL and occasionally with b-COP ( Fig. 1c-f ), we did not observe any co-localization of hVAPB P56S aggregates with the Golgi matrix protein GM130 or the mitochondrial marker, cytochrome c (Figure S2a and d) . AAV are thus effective gene expression platforms to study the impact of hVAPB wild-type and mutant over-expression on motoneuron functional integrity.
Over-expression of hVAPB WT and hVAPB P56S selectively triggers death of motoneurons We examined the consequence of the over-expression of VAP family members on motoneuron survival. After 24 h in culture, motoneurons were infected at the same m.o.i with AAV-hVAPB WT , AAV-hVAPB P56S , AAV-hVAPA or AAV-EGFP. According to the high-efficiency transduction of motoneurons by AAV, we directly counted, at the time indicated, the number of phase-bright neurons using morphological criteria as previously described (Raoul et al. 2002) . Regardless of the inherent toxicity of viral vectors (Appendix S1), the survival curves of motoneurons infected with AAV-hVAPA or AAV-EGFP motoneuron did not significantly vary over the time and were indistinguishable ( Fig. 2a) . In contrast, AAV-mediated expression of hVAPB WT induced rapid death of motoneurons, half of them dying by 1 day post-infection (DPI). Expression of hVAPB WT for a longer period (4 DPI) did not result in any further increase in cell death, even though expression of hVAPB WT continued in the surviving motoneurons (not shown). Interestingly, we observed that motoneurons infected with the disease-associated hVAPB P56S died more slowly than neurons infected with wild-type hVAPB (Fig. 2a) . It is noteworthy that the susceptibility of motoneurons to hVAPB P56S may not necessarily correlate with the presence of cytoplasmic inclusions. Indeed, at 2, 3 or 4 DPI, the surviving motoneurons showed an accumulation of hVAPB P56S into cytoplasmic aggregates (Fig. 1c-f and not shown).
To establish whether the vulnerability of motoneurons to hVAPBs over-expression might be relevant to pathogenesis of motoneuron disease, we determined the susceptibility of other neuronal types to hVAPB WT or hVAPB P56S overexpression. We first evaluated the efficacy of AAV6 to drive transgene expression in embryonic cortical and striatal neurons. We showed that 92.1 ± 1.9% of cortical and 91.3 ± 2.1% of striatal neurons were transduced by AAV-EGFP (mean ± SD, n = 3). The toxicity associated with AAV vectors was 14.9 ± 1.8% for cortical neurons and 18.6 ± 5.2% for striatal neurons (mean ± SD, n = 3). When both types of neurons were infected with AAV-hVAPB , AAV-hVAPA or AAV-EGFP. Contrary to motoneurons, we found that the survival of cortical and striatal neurons infected with AAV-hVAPB WT and AAV-hVAPB P56S was similar to the survival of those infected with AAV-hVAPA and AAV-EGFP viral vectors ( Fig. 2b and c) . These findings indicate that motoneurons are selectively vulnerable to increased levels of both wild-type and mutant VAPB.
AAV-based expression of hVAPB
WT and hVAPB P56S induces ER stress in motoneurons Three proximal sensors in mammalian cells trigger ER stress response: the IRE1, the double-stranded RNA-activated protein kinase-like ER kinase1 and the protein activating transcription factor 6 (ATF6). VAPB has been proposed to act in the ER stress response. Nevertheless, how VAPB contributes to the homeostatic response of ER to stress remains unclear. Indeed, over-expression of VAPB wild-type but not VAPB mutant, triggered activation of the IRE1 downstream effector, X-box binding protein (XBP1) in NSC34 cell line (Kanekura et al. 2006; Suzuki et al. 2009 ). In another study, over-expression of both wild-type and mutant VAPB attenuated ATF6/XBP1-dependent transcription in HEK293 and NSC34 cells (Gkogkas et al. 2008) . We therefore explored whether ER stress might contribute to the vulnerability of primary motoneurons to hVAPBs overexpression. Toward this goal, we determined by quantitative confocal microscopy the phosphorylation status of IRE1 in motoneurons. To identify motoneurons in an automated manner, we isolated them from Hb9::GFP mice in which, the motoneuron-selective Hb9 promoter drives expression of the GFP (Wichterle et al. 2002) . After validating the specificity of phospho-IRE1 immunoreactivity ( Figure S4 ), we revealed that the ER stress inducer thapsigargin, induced an IRE1-dependent ER stress response in Hb9::GFP motoneurons ( Fig. 3a and b) . As activation of IRE1 is an early key event in ER stress, we analyzed the phosphorylation levels of IRE1 6 h post-infection. As mentioned above, at this early time point, any native EGFP, that might interfere in the automated identification of Hb9::GFP motoneurons was not observed in normal neurons infected with AAV-EGFP. When motoneurons were infected both with AAV-hVAPB WT and AAV-hVAPB P56S , we found a significant increase in the immunofluorescence intensities of phosphorylated IRE1 (Fig. 3b) . In contrast, the mean phospho-IRE1 immunofluorescence of motoneurons infected with AAV-EGFP did not differ from that of non-infected cells (Fig. 3b) .
Salubrinal can act as a neuroprotective agent through inhibition of ER stress (Saxena et al. 2009 ). When added to culture media, we found that salubrinal saved motoneurons from death induced by over-expression of both hVAPB WT and hVAPB P56S (Fig. 3c) . We confirmed by counting the percentage of EGFP-positive motoneurons 4 DPI that salubrinal, at this concentration, did not lead to unspecific transcriptional or translational repression of the viral construct (AAV-EGFP-infected motoneurons, 100 ± 6.8%; AAV-EGFP-infected motoneurons treated with salubrinal, 94.1 ± 2.4% EGFP positive neurons at 4 DPI, mean ± SD, n = 3). These results suggest that ER stress is involved in death of motoneurons induced by over-expression of hVAPB WT and hVAPB
P56S
.
Motoneurons are more vulnerable than other neurons to an increase in intracellular Ca 2+ levels
We next explored whether the ER stress pathway underlies the selective vulnerability of motoneurons to AAV-mediated over-expression of hVAPB WT and hVAPB
. Motoneurons, cortical and striatal neurons were thus challenged with increasing concentrations of the ER stress inducer tunicamycin, an inhibitor of N-glycosylation. Tunicamycin induces death of motoneurons, cortical and striatal neurons in a dosedependent manner, and the dose response curve of motoneurons to tunicamycin did not significantly differ from that of cortical or striatal neurons (Fig. 4a) . To confirm this result, we used thapsigargin, which induces ER stress by 2+ homeostasis through a selective inhibition of the sarco/endoplasmic reticulum Ca 2+ ATPase. Interestingly, we observed that motoneurons show an increased susceptibility to thapsigargin-induced ER stress compared to cortical and striatal neurons (Fig. 4b) . This suggests that motoneurons might have an exacerbated susceptibility to aberrant Ca 2+ signals rather than to ER stress. With this in mind, we cultured motoneurons, cortical and striatal neurons in the presence of increasing concentrations of caffeine, an agonist of ryanodine receptors (RyRs) driving release of Ca 2+ from the ER. Caffeine does not significantly affect survival of cortical and striatal neurons, whereas under the same conditions, caffeine induces death of about 50% of motoneurons in a dose-dependent manner (Fig. 4c) 2+ transients in motoneurons, we isolated them from Hb9::GFP transgenic mice. Simultaneous dual-color imaging of GFP and the Ca 2+ -sensitive dyes FuraRed was performed 6 h post-infection to study early events taking place well before the resulting cell death (Fig. 5a ). At this time point, we were not able to detect any native EGFP fluorescence in AAV-EGFP-infected motoneurons that might interfere in the identification of Hb9::GFP motoneurons. We first showed that motoneurons, infected or not, respond to membrane depolarization by a Ca 2+ influx that leads to an increased [Ca 2+ ] i (Fig. 5a-c) . It is noteworthy that a trend (non-significant) towards greater basal Ca 2+ levels in motoneurons was seen following transduction with hVAPB WT and hVAPB P56S compared to EGFP (Fig. 5d ). When we determined the amplitude of the Ca 2+ response to high K + concentrations, we found that AAV-mediated expression of both hVAPB WT and hVAPB P56S led to a significant reduction in the amplitude of Ca 2+ transients (Fig. 5e ). This suggests that death of motoneurons, induced by over-expression of wild-type and mutant hVAPB, might rely on changes in the intracellular calcium homeostasis. signals from the ER store may intervene in the death pathway. We then evaluated the neuroprotective effect of dantrolene, a selective inhibitor of RyRs that antagonizes Ca 2+ -induced Ca 2+ release (CICR), on hVAPB-induced death. We first ensured that dantrolene did not unspecifically influence viral-mediated gene expression in motoneurons (AAV-EGFP, 100 ± 2.4%; AAV-EGFP with dantrolene, 94 ± 6.8% EGFP positive motoneurons at 4 DPI, mean ± SD, n = 3). We then showed that dantrolene significantly saved motoneurons from AAV-mediated over-expression of hVAPB WT and hVAPB P56S ( Fig. 6b and Figure S5b ), suggesting that activation of CICR via RyRs participates in Ca 2+ -dependent death signaling in motoneurons. Ca 2+ -induced Ca 2+ release has been demonstrated to participate in the generation of Ca 2+ transients elicited by aamino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA)/ Kainate (KA)-type glutamate receptors during spontaneously occurring excitatory post-synaptic currents in cultured motoneurons (Jahn et al. 2006) . Thus, we hypothesized that the impaired homeostatic regulation of Ca 2+ induced by hVAPB WT and hVAPB P56S would impact on survival through an aberrant response to AMPA/KA-mediated Ca 2+ influxes evoked by spontaneous inward currents. To address this question, we determined whether the AMPA/KA antagonist, NBQX, protected motoneurons from hVAPB WT and hVAPB P56S over-expression. As predicted, exposing motoneurons infected with AAV-hVAPB WT and AAVhVAPB P56S to NBQX, significantly rescues them from the degenerative process (Fig. 6c and Figure S5c ). We checked that NBQX did not lead to an unspecific repression of viralmediated gene expression (AAV-EGFP, 100 ± 7.9%; AAV-EGFP in the presence of NBQX, 93.6 ± 8.1% EGFP positive motoneurons at 4 DPI, mean ± SD, n = 3). Collectively, our results suggest that defective Ca 2+ signaling contributes to the death of motoneurons induced by the over-expression of hVAPB WT and hVAPB
. An ER-associated pathway is involved in death of motoneurons triggered by both hVAPB WT and hVAPB
Which Ca 2+ -dependent ER-related death executioners participate in motoneuron death following AAV-promoted over-expression of hVAPB WT and hVAPB P56S ? The role of Ca 2+ -activated cystein proteases, calpains, in neuronal death in response to Ca 2+ signals has been well documented (Raynaud and Marcilhac 2006) . To explore the functional involvement of calpains in hVAPB-induced death, we used the potent inhibitor of the ubiquitously expressed l-and m-calpain, MDL-28170 in our in vitro paradigm. We confirmed that at the indicated concentration MDL-28170 did not repress AAV-promoted transgene expression (AAV-EGFP, 100 ± 3%; AAV-EGFP in the presence of MDL-28170, 99.7 ± 5.1% EGFP positive motoneurons at 4 DPI, mean ± SD, n = 3). We subsequently found that treatment with MDL-28170 rescued AAV-hVAPB WT -and AAVhVAPB P56S -infected motoneurons from death ( Fig. 7a and Figure S5d ).
Caspase 12 is an ER resident caspase that plays an important role during ER stress-induced apoptosis. In addition, caspase 12 can be proteolytically activated by calpains following an elevation of intracellular Ca 2+ (Tan et al. 2006) . We found that caspase 12 mainly co-localized with hVAPB WT at the ER but barely co-localized with hVAPB mutant cytoplasmic aggregates in motoneurons ( Figure S6a ). When we irreversibly inhibited caspase 12 through the synthetic peptide z-ATAD-fmk, we saved motoneurons from death induced by over-expression of hVAPB WT and hVAPB
( Fig. 7b and Figure S6b ). We also ensured that z-ATAD-fmk did not influence AAV-mediated transgene expression by determining the percentage of motoneurons showing EGFP fluorescence 4 DPI (AAV-EGFP, 100 ± 4.3%; AAV-EGFP in the presence of z-ATAD-fmk, 96.8 ± 6.1%, mean ± SD, n = 3). Our data suggests that caspase 12, in spite of its different co-localization with wild-type and mutant VAPB, is a common effector of the motoneuron death process. Caspase 3 is the primary executioner caspase of the calpain-/caspase 12-dependent death pathway. To investigate whether caspase 3 contributed to hVAPB wild-type and mutant-induced death of motoneurons, we first probed motoneurons infected (or not) with AAV-EGFP, AAVhVAPB WT and hVAPB P56S with antibodies specific to the cleaved form of caspase 3. Consistent with the kinetics of death promoted by hVAPB WT and hVAPB P56S over-expression, the percentage of motoneurons showing an activation of caspase 3 associated with a nuclear pyknosis increased more rapidly when neurons were transduced with hVAPB WT (16 h post-infection), and more slowly when neurons were transduced with hVAPB P56S (3 days post-infection) (Fig. 7c-e) . To confirm the involvement of caspase 3 in the degenerative process in vitro, we employed the caspase 3/7 caspase inhibitor z-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-fmk, which saved motoneurons from death induced by hVAPB WT and hVAPB P56S over-expression ( Fig. 7f and Figure S6c ). All together, these results suggest that the death of motoneurons triggered by AAV-mediated over-expression of wild-type and mutant hVAPB implicates Ca 2+ -sensitive calpains and an ER-associated caspase cascade.
Discussion
The results presented in this study are consistent with a causative role of P56S mutant VAPB in motoneuron degeneration (Nishimura et al. 2004 (Nishimura et al. , 2005 . Here, we show that viral delivery of VAPB mutant selectively triggers death of cultured motoneurons. To our surprise, AAV-mediated overexpression of the wild-type form of VAPB, but not VAPA, also induces a selective death of motoneurons, with an even more rapid kinetics of death. The expression of hVAPB and hVAPB P56S leads to ER stress, which contributes to the death process. However, the selective susceptibility of motoneurons to VAPBs over-expression compared to cortical and striatal neurons is most likely explained by an altered homeostatic regulation of Ca 2+ signals. The implication of calpains, caspase 12 and caspase 3 completes this ERassociated Ca 2+ -dependent death pathway induced by overexpression of both wild-type and mutant hVAPB.
The unfolded protein response (UPR) facilitates folding, processing, export, and degradation of proteins originating from the ER under stress conditions. When the stressful insult is too over-whelming, or when UPR is chronically activated, cells undergo apoptosis through a specific ER stress response (Schroder and Kaufman 2005) . Recently, longitudinal gene expression profiling of ALS-vulnerable and ALS-resistant motoneurons in different SOD1 mutant models documented the critical role of ER stress in the selective susceptibility of motoneurons in the disease (Saxena et al. 2009 ). The accumulation of evidence that ER stress might also contribute to sporadic ALS, has highlighted the ER stress as an important physiopathologic mechanism in ALS (Ilieva et al. 2007; Atkin et al. 2008; Ito et al. 2009 ). Previous studies on the physiological involvement of VAPB in UPR and ER stress resulted in conflicting data as to whether VAPB WT can induce or reduce the UPR. However, the P56S mutation that leads to the formation of aggregates and recruitment of the wild-type protein into these aggregates is most likely associated with a reduction of the activity of UPR in cell lines (Kanekura et al. 2006; Gkogkas et al. 2008; Suzuki et al. 2009 ). The negative impact of mutant VAPB on UPR activity may bring into play either a dominant negative effect that would block the VAPB-mediated activation of IRE1/XBP1 pathway (Kanekura et al. 2006; Suzuki et al. 2009) or potentiate the inhibitory activity of VAPB wild-type on ATF6 activation (Gkogkas et al. 2008) . Here, we demonstrated that AAV delivery of both wild-type and mutated forms of VAPB led to activation of IRE1 (Fig. 3b) and that salubrinal, an ER-stress inhibitor that acts by preventing dephosphorylation of eukaryotic translation initiation factor-2 subunit-alpha, confered a neuroprotective effect (Boyce et al. 2005) (Fig. 3c) . In addition, the specific inhibition of caspase 12, a representative caspase involved in ER stress, saved motoneurons from VAPBs over-expression ( Fig. 7b and Figure S6b ). Several factors may account for the discrepancies between our observations and those made by other studies. Firstly, viral gene transfer achieved a moderate gene expression level that may establish more physiological levels of expression. Secondly, we used nontagged forms of VAPB proteins and it has been found that the nature and position of the tag sequence can influence the biochemical properties of the proteins (Suzuki et al. 2009 ). Perhaps more importantly, the use of primary motoneurons, displaying some intrinsic features of this neural cell type, may reveal more relevant pathogenic mechanisms.
It is striking that a proportion of motoneurons appeared intrinsically resistant to the over-expression both hVAPB WT and hVAPB P56S (Fig. 2a) . This differential vulnerability of motoneurons to hVAPBs over-expression may reflect the diversity of intrinsic properties of motoneurons. Indeed, a variegation of intrinsic features has been proposed to underlie the selective vulnerability of motoneuron subtypes in the disease (Wetts and Vaughn 1996; Pun et al. 2006) . In ALS mice, both ALS-resistant and ALS-vulnerable motoneurons show an early increase in ubiquitin signals, which might be regarded as a physiological response to mutant SOD1 misfolding. However, an activation of ER stress pathway selectively occurs in vulnerable subtypes (Saxena et al. 2009 ). Whether the motoneuron population sensitive to hVAPBs is the one that is more prone to ER stress response remains to be elucidated.
What might account for the selective vulnerability of motoneurons compared to other neuronal types? We observed a selective susceptibility of motoneurons to ERstress induced by perturbed calcium homeostasis (Fig. 4b ) compared to ER stress induced by accumulation of unfolded proteins (Fig. 4a) Viral delivery of neurodegenerative disease-associated genes provides convenient models to investigate pathoge-netic mechanisms in vitro. Cell-autonomous and noncell-autonomous feature of motoneuron vulnerability in motoneuron disease has been investigated using primary or embryonic stem cell-derived culture of wild-type or SOD1 mutant motoneurons. For example, the selective vulnerability of motoneurons to AMPA-mediated excitotoxicity associated with GluR2 deficiency (Van Damme et al. 2007) , the exacerbated susceptibility of motoneurons purified from SOD1 to the motoneuron-restricted Fas death pathway and its effector, the Collapsin Response Mediator Protein 4a (Raoul et al. 2002 (Raoul et al. , 2006 Duplan et al. 2010) , and the motoneuron-selective neurotoxic effects of SOD1 mutant damaged astrocytes (Pehar et al. 2004; Nagai et al. 2007) . Importantly, these culture systems complement genetic in vivo models for studies of physiopathological mechanisms and are instrumental in the development of therapeutic strategies (Van Damme et al. 2005 , 2007 Boillee et al. 2006; Locatelli et al. 2007; Yamanaka et al. 2008 ).
An important aspect of in vitro models relates to the etiological mechanisms underlying neurodegenerative diseases. Missense mutations in a-synuclein have been linked to autosomal dominant forms of Parkinson's disease. Experimental modeling of Parkinson's disease in vitro and in vivo through viral-based gene transfer approaches showed that over-expression of both the wild-type and mutant form of a-synuclein led to the death of dopaminergic neurons (Lo Bianco et al. 2002; Schneider et al. 2007 ). This suggests that increased endogenous levels of the wild-type protein can elicit neurotoxic effects in dopaminergic neurons in models. Interestingly, gene dosage effects resulting from the duplication or triplication of the a-synuclein gene was found to cause early-onset Parkinson's disease (Eriksen et al. 2005) . Gene dosage effects were also reported in Alzheimer's disease, where the duplication of the amyloid precursor protein gene has been linked to early-onset Alzheimer's disease (Rovelet-Lecrux et al. 2006) , and in the CharcotMarie-Tooth type 1A motor sensory neuropathy, with duplication of the peripheral myelin protein 22 gene (Valentijn et al. 1992) . Gene dosage effects, that have not yet been reported to cause ALS, might plausibly be another genetic factor in ALS.
Our data would indicate that the homeostatic function of VAPB within the ER is of a considerable biological significance in motoneurons. Abnormal expression levels of wild-type or expression of the mutated VAPB indeed led to the disregulation of ER homeostasis and resulted in motoneuron degeneration. A loss-of-function characterized by the aggregation of VAPB wild-type with or without other proteins has been hypothesized as the causal mechanism of ALS associated with P56S mutant VAPB (Kanekura et al. 2006; Teuling et al. 2007; Suzuki et al. 2009 ). The slower death kinetics observed following over-expression of VAPB mutant compared to wild-type VAPB could indeed result from a gradual depletion and subsequent loss-of-function of endogenous VAPB WT . Unfortunately, rescue experiments consisting in the over-expression of wild-type protein in the presence of mutant protein cannot be achieved in our in vitro model. However, activation of the IRE1 signal and impaired Ca 2+ homeostasis are early events that occur concomitantly following the forced expression of both VAPB WT and hVAPB P56S . A plausible alternative hypothesis is that the mutant protein acquired one or more toxic properties that converge to the same effectors elicited when levels of the wild-type protein are abnormal. Much is yet to be understood about underlying mechanisms of the VAPB mutant protein in the degeneration of motoneurons. Genetic models of VAPB, including transgenic and VAPB-deficient mice will therefore be crucial for completing our understanding of motoneuron biology. Our in vitro model has helped us to identify potential effector mechanisms, which have been demonstrated relevant to other FALS models and therefore represent potential therapeutic targets for motoneuron disease.
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